-
Something wrong with this record ?
Needleless emulsion electrospinning for the regulated delivery of susceptible proteins
M. Buzgo, E. Filova, AM. Staffa, M. Rampichova, M. Doupnik, K. Vocetkova, V. Lukasova, R. Kolcun, D. Lukas, A. Necas, E. Amler,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NV15-33094A
MZ0
CEP Register
NV16-29680A
MZ0
CEP Register
NV16-29680A
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2012-01-01
PubMed
28508471
DOI
10.1002/term.2474
Knihovny.cz E-resources
- MeSH
- Biocompatible Materials pharmacology MeSH
- Dextrans chemistry MeSH
- Emulsions chemistry MeSH
- Needles MeSH
- Collagen Type II metabolism MeSH
- Horseradish Peroxidase metabolism MeSH
- Mesenchymal Stem Cells cytology drug effects metabolism MeSH
- Intercellular Signaling Peptides and Proteins pharmacology MeSH
- Swine, Miniature MeSH
- Nanofibers chemistry ultrastructure MeSH
- Poloxamer chemistry MeSH
- Polyesters chemistry MeSH
- Swine MeSH
- Proteins administration & dosage MeSH
- Rhodamines chemistry MeSH
- Tissue Engineering methods MeSH
- Tissue Scaffolds chemistry MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
In the present work, we developed a novel needleless emulsion electrospinning technique that improves the production rate of the core/shell production process. The nanofibres are based on poly-ε-caprolactone (PCL) as a continuous phase combined with a droplet phase based on Pluronic F-68 (PF-68). The PCL-PF-68 nanofibres show a time-regulated release of active molecules. Needleless emulsion electrospinning was used to encapsulate a diverse set of compounds to the core phase [i.e. 5-(4,6-dichlorotriazinyl) aminofluorescein -PF-68, horseradish peroxidase, Tetramethylrhodamine-dextran, insulin growth factor-I, transforming growth factor-β and basic fibroblast growth factor]. In addition, the PF-68 facilitates the preservation of the bioactivity of delivered proteins. The system's potential was highlighted by an improvement in the metabolic activity and proliferation of mesenchymal stem cells. The developed system has the potential to deliver susceptible molecules in tissue-engineering applications.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045612
- 003
- CZ-PrNML
- 005
- 20201112110554.0
- 007
- ta
- 008
- 200109s2018 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/term.2474 $2 doi
- 035 __
- $a (PubMed)28508471
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Buzgo, Matej $u Department of Biophysics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Laboratory of Tissue Engineering, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. University Centre of Energetically Efficient Buildings, Czech Technical University, Buštěhrad, Czech Republic.
- 245 10
- $a Needleless emulsion electrospinning for the regulated delivery of susceptible proteins / $c M. Buzgo, E. Filova, AM. Staffa, M. Rampichova, M. Doupnik, K. Vocetkova, V. Lukasova, R. Kolcun, D. Lukas, A. Necas, E. Amler,
- 520 9_
- $a In the present work, we developed a novel needleless emulsion electrospinning technique that improves the production rate of the core/shell production process. The nanofibres are based on poly-ε-caprolactone (PCL) as a continuous phase combined with a droplet phase based on Pluronic F-68 (PF-68). The PCL-PF-68 nanofibres show a time-regulated release of active molecules. Needleless emulsion electrospinning was used to encapsulate a diverse set of compounds to the core phase [i.e. 5-(4,6-dichlorotriazinyl) aminofluorescein -PF-68, horseradish peroxidase, Tetramethylrhodamine-dextran, insulin growth factor-I, transforming growth factor-β and basic fibroblast growth factor]. In addition, the PF-68 facilitates the preservation of the bioactivity of delivered proteins. The system's potential was highlighted by an improvement in the metabolic activity and proliferation of mesenchymal stem cells. The developed system has the potential to deliver susceptible molecules in tissue-engineering applications.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biokompatibilní materiály $x farmakologie $7 D001672
- 650 _2
- $a kolagen typ II $x metabolismus $7 D024043
- 650 _2
- $a dextrany $x chemie $7 D003911
- 650 _2
- $a emulze $x chemie $7 D004655
- 650 _2
- $a křenová peroxidasa $x metabolismus $7 D006735
- 650 _2
- $a mezibuněčné signální peptidy a proteiny $x farmakologie $7 D036341
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $x účinky léků $x metabolismus $7 D059630
- 650 _2
- $a nanovlákna $x chemie $x ultrastruktura $7 D057139
- 650 _2
- $a jehly $7 D009339
- 650 _2
- $a poloxamer $x chemie $7 D020442
- 650 _2
- $a polyestery $x chemie $7 D011091
- 650 _2
- $a proteiny $x aplikace a dávkování $7 D011506
- 650 _2
- $a rhodaminy $x chemie $7 D012235
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a miniaturní prasata $7 D013556
- 650 _2
- $a tkáňové inženýrství $x metody $7 D023822
- 650 _2
- $a tkáňové podpůrné struktury $x chemie $7 D054457
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Filova, Eva $u Department of Biophysics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Laboratory of Tissue Engineering, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Staffa, Andrea Mickova $u Department of Biophysics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Laboratory of Tissue Engineering, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. University Centre of Energetically Efficient Buildings, Czech Technical University, Buštěhrad, Czech Republic.
- 700 1_
- $a Rampichova, Michala $u Laboratory of Tissue Engineering, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. University Centre of Energetically Efficient Buildings, Czech Technical University, Buštěhrad, Czech Republic.
- 700 1_
- $a Doupnik, Miroslav $u University Centre of Energetically Efficient Buildings, Czech Technical University, Buštěhrad, Czech Republic.
- 700 1_
- $a Vocetkova, Karolina $u Department of Biophysics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Laboratory of Tissue Engineering, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. University Centre of Energetically Efficient Buildings, Czech Technical University, Buštěhrad, Czech Republic.
- 700 1_
- $a Lukasova, Vera $u Laboratory of Tissue Engineering, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. University Centre of Energetically Efficient Buildings, Czech Technical University, Buštěhrad, Czech Republic.
- 700 1_
- $a Kolcun, Radka $u Department of Biophysics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Laboratory of Tissue Engineering, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Lukas, David $u Department of Nonwovens and Nanofibrous Materials, Technical University of Liberec, Liberec, Czech Republic.
- 700 1_
- $a Necas, Alois $u Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
- 700 1_
- $a Amler, Evzen $u Department of Biophysics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Laboratory of Tissue Engineering, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. University Centre of Energetically Efficient Buildings, Czech Technical University, Buštěhrad, Czech Republic.
- 773 0_
- $w MED00163778 $t Journal of tissue engineering and regenerative medicine $x 1932-7005 $g Roč. 12, č. 3 (2018), s. 583-597
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28508471 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20201112110551 $b ABA008
- 999 __
- $a ok $b bmc $g 1483880 $s 1084285
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 12 $c 3 $d 583-597 $e 20171129 $i 1932-7005 $m Journal of tissue engineering and regenerative medicine $n J. tissue eng. regen. med. $x MED00163778
- GRA __
- $a NV15-33094A $p MZ0
- GRA __
- $a NV16-28637A $a NV16-29680A $p MZ0 $p MZ0
- GRA __
- $a NV16-28637A $a NV16-29680A $p MZ0 $p MZ0
- LZP __
- $a Pubmed-20200109